This file includes the details surrounding the second PK sampling period. Study Description In critically ill patients not receiving extracorporeal membrane oxygenation (ECMO), pharmacokinetic (PK) st
Background Venoarterial extracorporeal membrane oxygenation (V-A ECMO) use to support patients in cardiac failure is increasing. Despite this increased use, predicting successful weaning from ECMO can
